FDA Advisory Committee votes in favour of the clinical
U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX study of Polivy in combination with......
WISe.ART Allows Artist to Showcase Their NFT Collection of
WISe.ART Allows Artist to Showcase Their NFT Collection of Art Created by Artificial Intelligence Algorithms GENEVA / Zug –......
Roche launches two new antibodies to identify key clinical
Recent advances in cancer genomics have deepened the medical community’s understanding of the molecular alterations in brain tumours, more precisely......
Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical
KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling in Germany/Switzerland Basel,......
Novartis announces the appointment of the
Gilbert Ghostine, CEO of the Swiss multi-national fragrances business Firmenich appointed Chairman-Designate of the future Sandoz BoardMr Ghostine to begin......
WISeKey Strengthens its North American Footprint by Signing
WISeKey Strengthens its North American Footprint by Signing a Partnership Agreement with Rep One, a Leading Sales Representative Organization in the......
SIKA EXCEEDED CHF 10 BILLION SALES MARK – RECORD EBIT
Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules SIKA EXCEEDED CHF 10 BILLION SALES MARK – RECORD EBIT ACHIEVED ......
WISeKey Semiconductors Expands its North American Footprint
WISeKey Semiconductors Expands its North American Footprint Through a Partnership with Impact Technical Sales, a Leading Massachusetts-based Sales......
WISeKey Announces the Development of WISe.Social, a New
WISeKey Announces the Development of WISe.Social, a New Authenticated Social Media Network Powered by WISeID Access to the network will be......
Basilea reports strong financial results 2022 based on
22% year-on-year increase of royalty income from antifungal Cresemba®Operating profit of CHF 18.5 million and net profit of CHF 12.1 millionStrengthened......